Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.

Surgical bioprosthetic aortic valves made ... After propensity-score adjustment, mean patient age was 67.4 years, about one-third were female, and more than one-quarter were classified as NYHA III/IV ...

The two companies have entered into a strategic partnership to exclusively commercialize Braile’s Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other ...

The company highlighted a study spanning eight years that compared the performance of surgical aortic valves made with its proprietary Resilia tissue to those without, showing reduced rates of ...

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older patients with severe aortic stenosis following transcatheter aortic-valve ...

A transcatheter aortic valve replacement system designed ... 2.7 cm 2 at baseline at 2.8 cm 2 at 1 year and 2 years, whereas mean gradient fell from 7.5 mm Hg at baseline to 4.2 mm Hg at 1 year ...

The company is looking to TMTT to support sales growth at a time when the larger transcatheter aortic valve replacement business has slowed. BTIG analysts are predicting TAVR sales will grow 3% in the ...

For over a decade, the McGill University Health Centre (MUHC) has been at the forefront of aortic valve innovation, advancing how we treat cardiac patients through minimally invasive approaches. That ...